Csenge Advisory Group’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Csenge Advisory Group’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12.2M	Buy	49,202 +17,582	+56%	+$3.79M	0.49%	34
2026 Q1	$6.35M	Buy	+31,620	New	+$6.54M	0.29%	68
2025 Q2	–	Sell	-54,039	Closed	-$8.23M	–	692
2025 Q1	$8.23M	Buy	54,039 +2,304	+4%	+$400K	0.47%	42
2024 Q4	$8.6M	Buy	51,735 +988	+2%	+$169K	0.47%	39
2024 Q3	$8.74M	Buy	50,747 +5,320	+12%	+$881K	0.46%	42
2024 Q2	$7M	Buy	45,427 +26,703	+143%	+$4.01M	0.4%	45
2024 Q1	$2.88M	Sell	18,724 -1,455	-7%	-$222K	0.16%	114
2023 Q4	$3.19M	Buy	20,179 +283	+1%	+$40.7K	0.2%	92
2023 Q3	$2.91M	Buy	19,896 +964	+5%	+$147K	0.2%	95
2023 Q2	$2.9M	Buy	18,932 +5,609	+42%	+$875K	0.19%	100
2023 Q1	$2.07M	Buy	13,323 +9,376	+238%	+$1.47M	0.15%	125
2022 Q4	$608K	Buy	+3,947	New	+$582K	0.05%	300
2020 Q3	–	Sell	-10,292	Closed	-$1.73M	–	406
2020 Q2	$1.73M	Buy	+10,292	New	+$1.62M	0.25%	77

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

Csenge Advisory Group's FBT Position: Q2 2026 in Review

Csenge Advisory Group increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 56% in Q2 2026, buying an estimated $3.79M and bringing the position to 49,202 shares worth $12.2M. The position accounts for 0.49% of the portfolio, ranked #34.

Csenge Advisory Group first reported a position in FBT in Q2 2020 and has held it in 13 quarters since. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

Csenge Advisory Group held 49,202 shares of First Trust NYSE Arca Biotechnology Index Fund worth $12.2M as of Q2 2026.
Csenge Advisory Group bought 17,582 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $3.79M.
First Trust NYSE Arca Biotechnology Index Fund made up 0.49% of Csenge Advisory Group's portfolio in Q2 2026, its #34 holding.
Csenge Advisory Group first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2020 and has held it in 13 quarters since.
339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Csenge Advisory Group's 13F filing for Q2 2026, filed 10 Aug 2026.